Prophylactic and acute treatment with the homeopathic medicine Betula 30c for birch pollen allergy: A double-blind, randomized, placebo-controlled study of consistency of VAS responses

British Homeopathic Journal

Volumn 90, Issue 2, 2001, Pages 73-78

  Aabel, S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Betula 30c; Birch pollen allergy; Hay fever; Homeopathy; Isopathy; VAS

Indexed keywords

SALICYLIC ACID METHYL ESTER;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HAY FEVER; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; NORWAY; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SEASONAL VARIATION; TREE;

EID: 0034982357     PISSN: 00070785     EISSN: None     Source Type: Journal    
DOI: 10.1054/homp.1999.0471     Document Type: Article

References (14)

1. Potent placebo or potency? A proposed study model with initial findings using homeopathically prepared pollens in hay fever
2. Is homoeopathy a placebo response? Controlled trial of homoeopathic potency, with pollen in hay fever as model
3. Is evidence for homoeopathy reproducible?
4. Randomized controlled trial of homeopathy versus placebo in perennial allergic rhinitis with overview of four trial series
5. Current status of immunotherapy for allergies and anaphylactic reactions
6. Is homeopathic 'immunotherapy' effective? A double-blind, placebo-controlled trial with the isopathic remedy Betula 30c for patients with birch pollen allergy
7. No beneficial effect of isopathic prophylactic treatment for birch pollen allergy during a low-pollen season: A double-blind, placebo-controlled trial with the homeopathic remedy Betula 30c
8. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study
9. Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
10. Rapid symptom relief in rhinitis
11. Long-term clinical efficacy of grass-pollen immunotherapy
12. A double blind study of the discontinuation of ragweed immunotherapy